Alcohol Use Disorder clinical trials
Showing 151–200 of 222 active trials. Describe your situation to see which ones you may be eligible for.
- Cannabis' Impact on Alcohol Consumption
- Enhancing Prospective Thinking in Early Recovery (HOME)
- Sex Differences in the Response to Abstinence From Alcohol.
- Behavioral and Functional Task Development, Implementation, and Testing
- Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function
- Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder
- Motivation for IV Alcohol Self-Administration in Humans
- Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design
- Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
- Effects of Ketogenic Diet on Alcohol Intoxication
- The Oklahoma Parent-Child Assistance Program
- Evaluating a One-Year Version of the Parent-Child Assistance Program
- Amplification of Positivity for Alcohol Use
- Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
- External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
- Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
- A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients
- PTSD and Alcohol Couples Treatment for Veterans
- Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
- A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerging Adults
- Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms
- Brief Alcohol Treatment for Women Veterans in Primary Care
- A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder
- Social Identity Mapping for Adolescent Recovery
- Combination Therapy for Alcohol Use Disorder
- OEA for Young Adults With Alcohol Use Disorder
- A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease
- The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veterans
- Deaf CBT-TS to Reduce Suicide Risk
- Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
- Advancing Scalable Alcohol Brief Interventions in the ED: A Trial of Conversational AI With Digital Reinforcements
- A Mindfulness-based Intervention for Sexual Assault Survivors
- Substance Use in Assault-Injured Young Adults
- Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults
- Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder
- Daridorexant for People With Insomnia and Alcohol Use Disorder Study
- Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults
- Pomegranate Dietary Supplements in AUD and ALD
- Effects of Nimodipine on Alcohol Drinking
- Pilot Study: Effects of Nimodipine on Alcohol Drinking
- Methylphenidate and Response to Alcohol Cues
- Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder
- Whole Selves User Testing and Feasibility Study
- Intervention for Alcohol Use Disorder Recovery After Liver Transplantation
- QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
- LDART for Alcohol Use Disorder
- Personalizing Treatment Delivery
- Addictions Neuroclinical Assessment (ANA)
- mHealth-supported Skills Training for Alcohol-Related Suicidality
- Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.